MP0533

· Molecular Partners AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MP0533, covering 2025-09-30 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1, Phase 2]